DANISH BIOTECH SPV I P/S: Financial statements 2015
CVR: 30274040
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
DANISH BIOTECH SPV I P/S (CVR 30274040) has filed annual accounts for 2015. In 2015, the company reported a gross profit of EUR -65,624 and a net result of EUR 12,592,518 compared with EUR -9,186,411 the year before. Equity in the 2015 report amounted to EUR 4,771,199. The solvency ratio was 18.3%.
- Gross Profit
- EUR -65,624
- Profit/Loss
- EUR 12,592,518
- Equity
- EUR 4,771,199
- Total Assets
- EUR 26,108,793
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -66K EUR | 12.6M EUR | 4.8M EUR | - |
| 2014 | - | -20K EUR | -9.2M EUR | -7.8M EUR | - |
| 2013 | - | -62K EUR | 11.7M EUR | 14.7M EUR | - |
| 2012 | - | - | -349K | 3.1M | - |
Official annual report
How creditworthy is DANISH BIOTECH SPV I P/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
DANISH BIOTECH SPV I P/S has published its annual report for 2014. Gross profit came to DKK -20,394, and the net result was DKK -9,186,411.
As of January 15, 2015, Martin David Mullins has joined the board of directors of DANISH BIOTECH SPV I P/S.
As of January 15, 2015, David Nicholas Charles Bolton is registered as chairman of DANISH BIOTECH SPV I P/S.
As of January 15, 2015, Sharon Rose Alvarez-Masterton has stepped down as chairman of DANISH BIOTECH SPV I P/S.
As of January 15, 2015, Sharon Rose Alvarez-Masterton has stepped down as director of DANISH BIOTECH SPV I P/S.
About DANISH BIOTECH SPV I P/S
DANISH BIOTECH SPV I P/S was a Danish company of the type Kommanditaktieselskab/Partnerselskab based in København V, founded in 2007. The company has been dissolved on 26 September 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named DKA I BIOTECH P/S. In 2021, the company reported a gross profit of EUR -25,339 and a net result of EUR 94,239 compared with EUR -32,410 the year before. Equity in the 2021 report amounted to EUR 45,320.
